Hims & Hers Health Q1 Financial Results Beat Estimates

Hims & Hers Health reported strong financial results for Q1, surpassing IBES estimates across key metrics. The company's adjusted EBITDA reached USD 91.1 million compared to the estimated USD 61.3 million. Additionally, the net income for the quarter was USD 49.5 million, exceeding the expected USD 28.2 million. Moreover, Hims & Hers Health generated revenue of USD 586 million, outperforming the estimated USD 538.2 million. The earnings per share (EPS) stood at USD 0.2, higher than the anticipated USD 0.12.

Latest News

05-07

Stock Track | Hims & Hers Health Soars 5% as Momentum Continues Following Earnings Beat and Analyst Upgrade

05-07

异动解读 | Hims & Hers Health股价盘中大涨5.01%，强劲财报和新合作推动增长

05-07

Stock Track | Hims & Hers Health (HIMS) Plunges 5% in Pre-market After Previous Day's Surge

User Discussion

Gehlot

05-06

$Hims & Hers Health Inc.(HIMS)$ Exceptional Revenue Growth: Revenue surged by 111% year-over-year to $586.0 million. Online revenue saw an even larger increase of 115% to $576.4 million. Wholesale revenue experienced a slight decrease of 7% year-over-year, falling to $9.6 million. Strong Profitability and Cash Flow: The company achieved a net income of $49.5 million, a significant increase from $11.1 million in Q1 2024. Adjusted EBITDA reached $91.1 million, up from $32.3 million in the same period last year. Operating cash flow was robust at $109.1 million, with a free cash flow of $50.1 million. Substantial Subscriber Growth and Engagement: The subscriber base grew by 38% year-over-year to 2.4 million. Notably, over 1.4 million subscri

{"i18n":{"language":"en_US"},"financialEventData":{"themeId":"3ef121fe4b5392b5fd7e9597977d399a","name":"Hims & Hers Health Q1 Financial Results Beat Estimates","description":"Hims & Hers Health reported strong financial results for Q1, surpassing IBES estimates across key metrics. The company's adjusted EBITDA reached USD 91.1 million compared to the estimated USD 61.3 million. Additionally, the net income for the quarter was USD 49.5 million, exceeding the expected USD 28.2 million. Moreover, Hims & Hers Health generated revenue of USD 586 million, outperforming the estimated USD 538.2 million. The earnings per share (EPS) stood at USD 0.2, higher than the anticipated USD 0.12.","image":"https://community-static.tradeup.com/news/1201dcc0482be040348fb8d4f228bb68","type":2,"style":4,"follow":false,"createTime":1746476135006,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":3ef121fe4b5392b5fd7e9597977d399a}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["HIMS"],"tweetCounts":1,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"Hims & Hers Health Q1 Financial Results Beat Estimates","tweetAmount":1,"imageIsDefault":false,"aiDerivativeIssues":[]},"news":[{"id":250888,"article_id":"1186017407","title":"Stock Track | Hims & Hers Health Soars 5% as Momentum Continues Following Earnings Beat and Analyst Upgrade","subtitle":"","subtitle_show":0,"pub_time":1746628528809,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":250887,"article_id":"1114791963","title":"异动解读 | Hims & Hers Health股价盘中大涨5.01%，强劲财报和新合作推动增长","subtitle":"","subtitle_show":0,"pub_time":1746628528807,"source_id":"ai_movement_cn","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":250403,"article_id":"1142608913","title":"Stock Track | Hims & Hers Health (HIMS) Plunges 5% in Pre-market After Previous Day's Surge","subtitle":"","subtitle_show":0,"pub_time":1746611959835,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":250402,"article_id":"1156726378","title":"Stock Track | Hims & Hers Health Plunges 5% Pre-Market Despite Q1 Beat as Long-Term Guidance Disappoints","subtitle":"","subtitle_show":0,"pub_time":1746611942175,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":250401,"article_id":"1174974587","title":"异动解读 | Hims & Hers Health盘前大跌5.03%，此前财报超预期股价大涨18%","subtitle":"","subtitle_show":0,"pub_time":1746611942174,"source_id":"ai_movement_cn","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":249724,"article_id":"2533010656","title":"BUZZ-Hims & Hers 第一季度业绩超预期后上涨","subtitle":"","subtitle_show":0,"pub_time":1746545250000,"source_id":"reuters_news_zh","language":"zh","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4S3RE1Q6:1","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null},{"id":249651,"article_id":"1114971627","title":"Stock Track | Hims & Hers Health Soars 5% Pre-Market on Strong Q1 Results and Analyst Upgrades","subtitle":"","subtitle_show":0,"pub_time":1746539525228,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":249641,"article_id":"2533763485","title":"Hims & Hers Health Shares Rise 5.7% After Q1 Revenue Beats Estimates","subtitle":"","subtitle_show":0,"pub_time":1746538799478,"source_id":"reuters_en_live","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nFWN3RE14D:1","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null},{"id":249285,"article_id":"1199711051","title":"Stock Track | Hims & Hers Health Plunges 5% After Hours Despite Strong Q1 Results as Q2 Guidance Disappoints","subtitle":"","subtitle_show":0,"pub_time":1746497697922,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":249284,"article_id":"1196033001","title":"异动解读 | Hims & Hers Health一季度业绩超预期，但盘后股价大跌5%","subtitle":"","subtitle_show":0,"pub_time":1746497697920,"source_id":"ai_movement_cn","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":249057,"article_id":"1107768588","title":"Stock Track | Hims & Hers Health Plunges 5.13% After-Hours Despite Strong Q1 Results as Guidance Disappoints","subtitle":"","subtitle_show":0,"pub_time":1746480539791,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":249056,"article_id":"1182220318","title":"异动解读 | Hims & Hers Health盈利超预期，股价却盘后大跌5.13%","subtitle":"","subtitle_show":0,"pub_time":1746480539789,"source_id":"ai_movement_cn","language":"zh","url":"","is_publish_highlight":0,"symbols_score_info":{"HIMS":1},"rights":null},{"id":249023,"article_id":"2533040565","title":"Hims & Hers Health Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要","subtitle":"","subtitle_show":0,"pub_time":1746478961000,"source_id":"reuters_news_zh","language":"zh","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL4S3RD1SG:1","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null},{"id":249019,"article_id":"2533565515","title":"Hims & Hers Health Q1 Earnings, Revenue Rise","subtitle":"","subtitle_show":0,"pub_time":1746477925000,"source_id":"mtnewswires_news","language":"en","url":"https://www.mtnewswires.com/","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null},{"id":249017,"article_id":"2533956302","title":"Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares Slide","subtitle":"","subtitle_show":0,"pub_time":1746477830000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/general/health-care/25/05/45208186/hims-hers-health-q1-earnings-revenue-jumps-111-subscribers-up-38-q2-guidance-falls-short-of-estimates-shares-slide","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null},{"id":249018,"article_id":"2533563225","title":"Hims & Hers Health 1Q Revenue Jumps; 2Q Sales Outlook Misses Analyst Expectations","subtitle":"","subtitle_show":0,"pub_time":1746477360000,"source_id":"dowjones_highlight","language":"en","url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":0,"symbols_score_info":{},"rights":null},{"id":248974,"article_id":"2533755041","title":"Hims & Hers Health Q1 EPS $0.20 Beats $0.12 Estimate, Sales $586.01M Beat $538.20M Estimate","subtitle":"","subtitle_show":0,"pub_time":1746475679000,"source_id":"benzinga_earnings","language":"en","url":"https://www.benzinga.com/news/earnings/25/05/45206633/hims-hers-health-q1-eps-0-20-beats-0-12-estimate-sales-586-01m-beat-538-20m-estimate","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null},{"id":248975,"article_id":"2533550956","title":"BRIEF-Hims & Hers Health Q1 Revenue USD 586 Million Vs. IBES Estimate USD 538.2 Million","subtitle":"","subtitle_show":0,"pub_time":1746475546308,"source_id":"reuters_news_en","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLX42F26E:1","is_publish_highlight":0,"symbols_score_info":{"HIMS":0.9},"rights":null}],"views":[],"tweetList":[{"id":431946032595624,"gmtCreate":1746479076253,"gmtModify":1746479086621,"author":{"id":"4184660311217232","authorId":"4184660311217232","name":"Gehlot","avatar":"https://community-static.tradeup.com/news/53dc63242823ec77ec80ac52b1cdf5e2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4184660311217232","authorIdStr":"4184660311217232"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a>&nbsp; Exceptional Revenue Growth: Revenue surged by 111% year-over-year to $586.0 million. Online revenue saw an even larger increase of 115% to $576.4 million. Wholesale revenue experienced a slight decrease of 7% year-over-year, falling to $9.6 million. Strong Profitability and Cash Flow: The company achieved a net income of $49.5 million, a significant increase from $11.1 million in Q1 2024. Adjusted EBITDA reached $91.1 million, up from $32.3 million in the same period last year. Operating cash flow was robust at $109.1 million, with a free cash flow of $50.1 million. Substantial Subscriber Growth and Engagement: The subscriber base grew by 38% year-over-year to 2.4 million. Notably, over 1.4 million subscri","listText":"<a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a>&nbsp; Exceptional Revenue Growth: Revenue surged by 111% year-over-year to $586.0 million. Online revenue saw an even larger increase of 115% to $576.4 million. Wholesale revenue experienced a slight decrease of 7% year-over-year, falling to $9.6 million. Strong Profitability and Cash Flow: The company achieved a net income of $49.5 million, a significant increase from $11.1 million in Q1 2024. Adjusted EBITDA reached $91.1 million, up from $32.3 million in the same period last year. Operating cash flow was robust at $109.1 million, with a free cash flow of $50.1 million. Substantial Subscriber Growth and Engagement: The subscriber base grew by 38% year-over-year to 2.4 million. Notably, over 1.4 million subscri","text":"$Hims & Hers Health Inc.(HIMS)$ Exceptional Revenue Growth: Revenue surged by 111% year-over-year to $586.0 million. Online revenue saw an even larger increase of 115% to $576.4 million. Wholesale revenue experienced a slight decrease of 7% year-over-year, falling to $9.6 million. Strong Profitability and Cash Flow: The company achieved a net income of $49.5 million, a significant increase from $11.1 million in Q1 2024. Adjusted EBITDA reached $91.1 million, up from $32.3 million in the same period last year. Operating cash flow was robust at $109.1 million, with a free cash flow of $50.1 million. Substantial Subscriber Growth and Engagement: The subscriber base grew by 38% year-over-year to 2.4 million. Notably, over 1.4 million subscri","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/431946032595624","isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}]}